SUMMARY The pathogenesis of the anaemia associated with rheumatoid disease is unclear. It has previously been shown that the degree of the anaemia correlates with the severity of the inflammatory disease and that serum from patients with arthritis inhibits erythropoiesis. This study was designed to examine whether interleukin 1 could be a mediator of the anaemia in rheumatoid arthritis. Radioimmunoassay of interleukin 1 in serum showed that patients with rheumatoid arthritis and associated anaemia had significantly higher interleukin 13 concentrations than patients with rheumatoid arthritis without anaemia. Pure recombinant human interleukin la and interleukin 113, in concentration ranges similar to those found in the arthritic patients, markedly suppressed the colony formation of the erythroid, but not the granulocyte-macrophage progenitor cells in cultures of normal bone marrow. Natural human interleukin 1 and recombinant interleukin 113, but not interleukin la, suppressed in a dose dependent manner the proliferation of the human erythroleukaemia cell line (HEL) in cultures, suggesting that the interleukin 1 effect is a direct one. The results show that interleukin 1 is a humoral inhibitor of erythropoiesis and suggests that interleukin 1 is involved in the development of anaemia in association with rheumatoid arthritis.
Mechanism of anaemia in rheumatoid arthritis 973 similar to those found in the patients with arthritis suppresses colony formation of the erythroid, but not the granulocyte-macrophage precursor cells, in normal bone marrow. The suppressive effect appears to be a direct one as natural ILl and recombinant human IL1l3 suppress the proliferation of an erythroid-like malignant cell line, HEL, in culture.
Subjects and methods

SUBJECTS
Serum samples from 20 patients with classical or definite RA were studied. Ten of the patients (eight women, two men, mean age 55.5 years, range had no anaemia (haemoglobin 139 (SD 10 1) g/l, range 126-162) and 10 patients (all women, mean age 64-7 years, range 38-77) had mild anaemia (haemoglobin 105 (6. 3) g/l, range [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] . No patient had signs of gastrointestinal bleeding or renal impairment, and no cause of the anaemia other than the underlying RA was found.
Twenty one blood donors (10 women, 11 men, mean age 40 years, range 21-72) served as normal control subjects.
BONE MARROW CULTURES
Bone marrow was obtained from five normal bone marrow donors. Erythroid progenitor cells BFU-E (burst forming units, erythroid) and CFU-E (colony forming units, erythroid) were cultured in methylcellulose as previously described by Iscove et Table 1 ). The serum concentrations of the acute phase reactants serum amyloid A and C reactive protein were significantly higher (p<OOl) in the anaemic patients than in the non-anaemic subjects (Table 1) .
EFFECT OF ILl ON ERYTHROPOIESIS
In cultures of normal bone marrow progenitor cells recombinant human ILla and IL1 suppressed the colony formation of the erythroid precursors BFU-E and CFU-E but had no inhibitory effect on the granulocyte-macrophage progenitors CFU-GM (Fig. 2) . The ILl effect on the erythroid colony formation was dose dependent; an ILl concentration of O1 lgig/l caused on average about 50% inhibition (Fig. 2) . group.bmj.com on July 6, 2017 -Published by http://ard.bmj.com/ Downloaded from Indirect evidence for raised ILl concentrations in the patients with RA and associated anaemia was obtained by finding significantly increased concentrations of serum amyloid A and C reactive protein in these patients, as ILl induces the hepatic acute phase protein synthesis.21 Direct evidence was obtained by radioimmunoassay of serum ILl,. Raised concentrations were found in the patients with RA, those with anaemia having significantly higher concentrations than those without anaemia.
Although not directly comparable, it should be noted that the raised serum concentrations of IL1,3
found in the patients with arthritis were in the concentration range that caused a significant supression of the colony formation of the erythroid progenitor cells in the marrow culture experiments. Although the anaemic patients with RA had significantly higher IL1l3 concentrations than the nonanaemic patients, raised concentrations were also found among the patients with RA without anaemia (who also had raised acute phase protein concentrations) and even in a few blood donors. This finding is not surprising in view of the previous demonstrations of ILl-like activity in the plasma of healthy subjects after exercise38 or ovulation,39 and of the role of ILl as a mediator of the acute phase reaction in inflammatory conditions. It has been shown that after activation by a variety of different stimuli,7 18 including interferons48 and tumour necrosis factor,49 macrophages/monocytes produce/release ILl. Some tumour cells are also capable of producing ILl, j which would explain the cancer cell mediated inhibition of erythropoiesis.
Our contention that ILl has a central role in the pathogenesis of the anaemia of RA does not exclude the possibility that other factors are involved, nor does it rule out interactions between various cytokines. Growing evidence suggests that in addition to having a potential role in the mediation of host defence against neoplastic cell growth and parasite infection tumour necrosis factor a has important regulatory functions in normal cell metabolism.5' 52
The actions of tumour necrosis factor and ILl are very similar in many processes associated with inflammation. In addition, recombinant tumour necrosis factors appear to mediate the haematopoietic colony inhibitory activity of natural killer cells, showing synergism with interferon gamma in this respect.53 4 The colony inhibiting activity of natural killer cells, however, is primarily directed against the granulocyte-macrophage cell line and not the erythroid cell line. Moreover, in a recent report Peetre et al showed that the erythroid progenitors were less susceptible to the action of tumour necrosis factor than were the granulocytemacrophage progenitors.55
In conclusion, based on the results of the present study, it is suggested that in situations of protracted overproduction ILl, a hormone-like intercellular mediator, which is primarily involved in host defence mechanisms, may not only be involved in the pathogenesis of muscle breakdown, coagulopathy, and reactive amyloidosis of chronic inflammatory diseases8 but also in the development of the anaemia of these conditions. 
